The European Medicines Agency has updated the ICH Q2(R2) Guideline on validation of analytical procedures. The update final adoption was in December 2023 and will come […]

Burundi has new regulatory texts dating from the end of 2023 and the beginning of 2024, the said texts have just entered into force.  These texts […]

During the Council of Ministers in Ivory Coast, Wednesday February 14, 2024, the decree ratifying the Creation of the African Medicines Agency (AMA) was adopted. Once […]

AREMA top management will be visiting ARAB HEALTH from 29 January to 1 February, 2024AREMA with our unparalleled experience globally and especially with local representation in […]

On the 26th of January 2024, the European Medicines Agency (EMA) has received a grant of ten million euros from the European Commission to support the establishment […]

The Economic Community of West African States (ECOWAS) published in August 2023, a new guide called “Approval of pharmaceutical products for human use in the Economic […]

On July 12, 2023, Tunisia published in the Official Gazette of the Republic of Tunisia (JORT) an important law, Law No. 2 of the year 2023, […]

9 April 2021: Zina Kobbi CEO of AREMA will be the Keynote Speaker on the virtual conference “United Conference of Generic Medicine, Vaccines and Biosimilars” to […]

New guideline of bioequivalence was recently implemented in Morocco by the drug agency, Ministry of Health the link to the document: http://dmp.sante.gov.ma/upload/uploadinterne/Lignes%20directrices%20bioequivalence%20Maroc.pdf